Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.
about
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancerHpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomachTranslationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives.Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation.Dihydroartemisinin Exerts Anti-Tumor Activity by Inducing Mitochondrion and Endoplasmic Reticulum Apoptosis and Autophagic Cell Death in Human Glioblastoma Cells.Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics.Current Understanding of the TCTP Interactome.The Translational Controlled Tumour Protein TCTP: Biological Functions and Regulation.Structural Insights into TCTP and Its Interactions with Ligands and Proteins.Antitumor Research on Artemisinin and Its Bioactive Derivatives.Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo.
P2860
Q33691704-BDEB9DB6-9983-45F6-BB44-95C4913509E9Q33720199-B00BF3F4-01B9-4BB2-B362-53BA4FFA1F49Q37618598-2D5B9F84-894C-4DEA-A4F8-C7C4AE13CE9FQ38756298-B28E73E5-A13D-4A1C-9215-DDA81A2A0A58Q42209977-9CE407DA-C173-45B3-ACE4-34327C5C3B73Q42369800-CA67A869-8546-43F4-8ACD-AD9D79007033Q47100761-57318A32-63BB-41CD-9473-6D79534CF828Q47144950-EE16ABCC-CEE7-4F19-A6C1-7574A4BD6D45Q47391605-124B61C3-A318-4D2C-B8F7-B3E87D865852Q47391614-80B37696-7F8D-4E99-A66B-333D545F0105Q47391630-EB48711D-45A0-4955-90FB-EEF9F31A88BBQ52597265-973AEC1A-023F-46DC-BDC2-C41DB2290F66Q55120322-AF330903-8102-4230-9B5B-BBE68056B5AE
P2860
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@ast
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@en
type
label
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@ast
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@en
prefLabel
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@ast
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Phospho-TCTP as a therapeutic ...... ggressive breast cancer cells.
@en
P2093
Dario Dezi
Ester Antelmi
Filippo De Braud
Giuseppe Nicotera
Lorenzo Sica
Manuela Zonfrillo
Maria Lucibello
Maria Luisa Carcangiu
Pasquale Pierimarchi
Sara Adanti
P2860
P304
P356
10.18632/ONCOTARGET.2971
P407
P577
2015-03-01T00:00:00Z